DLD Asset Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

DLD Asset Management’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-60,000	Closed	-$3.59M	–	126
2019 Q4	$3.59M	Buy	+60,000	New	+$2.25M	0.19%	42

DLD Asset Management's BOLD Position: Q1 2020 in Review

DLD Asset Management sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 60,000 shares — an estimated $3.59M sold.

DLD Asset Management first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $3.59M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

DLD Asset Management reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
DLD Asset Management sold 60,000 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $3.59M.
DLD Asset Management first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
DLD Asset Management's Audentes Therapeutics, Inc position peaked at $3.59M in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on DLD Asset Management's 13F filing for Q1 2020, filed 14 May 2020.